A Multidimensional Approach to Safety and Efficacy in Radiopharmaceuticals
Alan Montgomery1.
1MQSA, Johnson & Johnson, Raritan, NJ, United States
The rapid growth of the radiopharmaceutical industry necessitates a renewed focus on safety and efficacy, particularly in the areas of patient and healthcare provider exposure. This presentation will lay out a comprehensive analysis of current practices and emerging trends in radiopharmaceuticals, with a specific emphasis on radiation dose measurement and control. We explore innovative methodologies for accurately quantifying radiation doses received by patients and medical personnel, ensuring adherence to safety and regulatory standards. The discussion extends to the challenges in assessing the sterility of radioactive drugs, a critical aspect often overshadowed by radiation safety concerns. Our review will integrate technological advancements in radiation measurement and best practices in pharmaceutical industry. The aim is to provide an actionable framework for healthcare providers, researchers, and policymakers, fostering a safer and more effective use of radiopharmaceuticals in medical practice. The presentation concludes with recommendations for future research and development, highlighting the need for interdisciplinary collaboration to address these complex challenges in the radiopharmaceutical industry.